BD integrated microbiology solutions From a trusted partner in diagnostics

From positive blood culture to identification and susceptibility testing, BD informs healthcare professionals to help provide timely and targeted therapeutic decisions.

Integrated solutions from specimen collection to final resultBD informatics solutions provide secure, scalable connectivity, delivering actionable insights to improve laboratory productivity and facilitate timely and appropriate decisions

Pre-analytical • BD Chloraprep™ skin preparation products

• BD Vacutainer® UltraTouch™ push button bloodcollection set

• BD BACTEC™ blood culture media

• BD Synapsys™ microbiology informatics solution

Analytical • BD BACTEC™ FX blood culture instruments

• BD Bruker MALDI Biotyper™ system

• BD Phoenix™ Automated Microbiology Systemfor identification and susceptibility testing

Post-analytical • BD EpiCenter™ data management system

• BD Synapsys™ microbiology informatics solutionfor blood culture

• Improve detection of positive blood cultures1-3

• Standardize the preparation of testing for ID/AST testing

• Accurately report ID/AST results in a timely manner

• Obtain insights to improve blood collection best practices,enhance operational outcomes and streamline laboratoryworkflow

• Communicate critical results more efficiently to clinicians

By delivering a comprehensive workflow solution for suspected sepsis, from specimen collection to data management, including identification and susceptibility testing, BD can help healthcare professionals:

BD Vacutainer®

blood collection set

BD Bruker MALDI Biotyper™ system

BD Phoenix™ identification and susceptibility testing systems

BD Synapsys™ microbiology informatics solution

BD Chloraprep™ skin preparation products

BD EpiCenter™ data management system

CONNECTED

INTEG

RATED EMPO

WER

ED

BD Synapsys™

Solution

Secureinstrumentconnectivity

Integratedworkflows

On-demand actionable

insights

Anytime,anywhereaccess

BD BACTEC™ FX blood culture system

BD BACTEC™ blood culture media

BD integrated clinical microbiology solutions Microbiology laboratories face many challenges in an ever-changing environment: • Antimicrobial resistance is rising

• Staffing shortages combined with increased testingvolumes

• Financial pressures due to consolidation, decliningreimbursement, and increasing competition

Improve operational efficiencies and potentially reduce the need for repeat testing5-7,9

BD provides end-to-end, integrated clinical microbiology solutions enabling healthcare professionals to:

Achieve accuracy in organism recovery and identification and susceptibility testing to help inform clinicians on treatment guidance decisions

Potentially reduce laboratory turnaround times

✓✓

✓

Helping to reduce laboratory turnaround times

As a leader in blood culture testing, the BD BACTEC™ blood culture system has been helping to accurately identify positive blood cultures for more than 50 years. Combining this expertise with a comprehensive identification and susceptibility platform, BD provides accurate and timely test results, which may help clinicians guide antimicrobial therapy.5

• Reduced time to detection with BD BACTEC blood culturemedia, supporting faster recovery of both aerobic andanaerobic organisms1-3

• Minimized delays in blood culture processing with satellitetesting options, powered by BD Synapsys microbiologyinformatics solutions

• Rapid, accurate identification and susceptibility with BDBruker MALDI BioTyper™ and BD Phoenix™ system

• Timely communication of critical test results to clinicianswith BD Synapsys informatics

Achieve accuracy in organism recovery and identification and susceptibility testing to help inform clinicians on treatment guidance.

BD offers a broad portfolio of blood culture solutions that help optimize organism recovery. To achieve accurate identification results, BD has partnered with Bruker, an established leader in MALDI-TOF technology.8 By combining this rapid identification with the BD identification and susceptibility testing solutions,BD provides clinicians with accurate and timely results to help guide their therapyand patient management decisions.

• Improved specimen quality with BD collection and transport solutions, along withmedia formulations optimized for organism recovery1-3,9-10

• Demonstrated ability to detect emerging resistance with unique dual growth detectiontechnology as compared to other testing solutions

• Intuitive on-demand antibiogram generation with flexible reporting options

✓

✓

Improve operational efficiencies and potentially reduce the need for repeat testing.5-7,9

BD provides modular and integrated products powered by scalable software solutions that may enhance workflow in labs of all sizes and complexity.

• BD blood culture media bottles integrate with BD Vacutainer blood collection sets,minimizing the need to use costly adapters

• BD BACTEC™ Plus Aerobic Medium and BD BACTEC™ Lytic Anaerobic Medium havebeen associated with lower mortality rates and decreased length of stay4

• BD Bruker MALDI Biotyper and BD Phoenix identification and susceptibility testingsolutions provide accurate results, enabling clinicians to de-escalate antibiotics in atimely manner, which may help limit the spread of resistance and control unnecessaryhospital costs

• BD Synapsys informatics supports laboratories in meeting their compliance needs

From positive blood culture to identification and susceptibility testing and result reporting, BD provides an integrated and trusted microbiology solution.

✓

BD, Sparks, MD, 21152, USA 800.638.8663

bd.com© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. 223033-US December 2018

1. Almuhayawi M, et al. PLOS ONE. 2015;10(11): e0142398.2. Zadroga R et al. Selection of blood culture media matters—BACTEC use in the critically ill facilitates earlier organism detection and antibiotic decision making. Poster presented at:

2013 World Federation of Societies of Intensive and Critical Care Medicine Congress; August 28–September 1, 2013; Durban, South Africa.3. Zheng S et al. PLOS ONE. 2016;11(10): e0164668.4. Wolk DM et al. Characterization of clinical improvements after implementation of new blood culture strategy for severe sepsis patients. Poster presented at; 2016 ID Week; October 26-30

2016; New Orleans, Louisana.5. Beavers-May, T.K., et al. Interventional Microbiology: Utility of the BD EpiCenter and Sentinel in Management of S. aureus in Pediatric Hospital Patients. Poster presented at; 2008 ASM.6.Jungkind,D.L.WorkflowEvaluationoftheBDPhoenixAPSystemcomparedtotheMicroScanwalkawayovernightsystemforidentficationandsusceptibilitytestingofbacteria.

Presented at American Society of Microbiology, May, 2010, San Diego, CA7. Junkins, A. et al. J. Clin Microbiology 2010 Vol. 48. No. 5, P. 1929-19318. https://www.bruker.com/applications/microbiology.html9. Tepus D. et al. J Nurs Care Qual. 2008;23(3); 272-276

10. Dataonfile,BD,FranklinLakes,NJ